spacer
home > epc > media info
MEDIA INFORMATION

Click here to view the EPC media pack

EPC offers an industry-leading platform, which includes:
  • An international readership of pharma and biotech decision-makers, plus full-service and speciality CROs, in print and online
  • Strong, opinion-led editorial comment and analysis
  • Affiliation with international trade events and conferences
  • An impressive record of long-term advertising partnerships and a loyal affiliate network
  • Multimedia presence to reach a global audience
Each edition of EPC runs a number of expert, discussion-based features on the latest contract research and outsourcing moves. Topics regularly covered include:
  • CRO market analysis
  • Biopharmaceutical development
  • Non-clinical pharmacology/toxicology
  • Laboratory services (bioanalytical labs, central labs)
  • Biosimilars development
  • Biomarkers and assay development
  • Data management
  • Biostatistics
  • Pharmacovigilance
  • Chemistry, manufacturing, controls
  • Strategic and regulatory planning
  • Pricing and market access
  • Contract planning
  • Outsourcing models (eg full service, functional service provider)
  • Supplier selection
  • Managing supplier relationships
  • Procurement practices
  • Technical innovation
  • Business process management
  • CRO performance metrics
spacer



Published quarterly in
February, May,
August and November
 
Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 
News and Press Releases

Navigating the new Clinical Trial Regulation with DIA

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will have a dramatic impact. The aim of the change in regulation is to increase the efficiency of all trials in Europe, as well as promoting research while avoiding the duplication of clinical trials
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement